Stealth BioTherapeutics Corp - ESG Rating & Company Profile powered by AI
If you work at Stealth BioTherapeutics Corp and you wish to use your Sustainability rating, please contact us. Jump to the bottom of this webpage for potential risks for Stealth BioTherapeutics Corp based on sector, geography and size. This analysis of Stealth BioTherapeutics Corp is prepared by All Street Sevva using leading machine learning.
Stealth BioTherapeutics Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 5.3, social score of 1.6 and governance score of 6.0.
4.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
910 | Vaxcyte Inc | 4.4 | High |
910 | Yield10 Bioscience Inc | 4.4 | High |
951 | Stealth BioTherapeutics Corp | 4.3 | High |
951 | Cerecor Inc | 4.3 | High |
951 | Allergy Therapeutics PLC | 4.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Stealth BioTherapeutics Corp have an accelerator or VC vehicle to help deliver innovation?
Does Stealth BioTherapeutics Corp disclose current and historical energy intensity?
Does Stealth BioTherapeutics Corp report the average age of the workforce?
Does Stealth BioTherapeutics Corp reference operational or capital allocation in relation to climate change?
Does Stealth BioTherapeutics Corp disclose its ethnicity pay gap?
Does Stealth BioTherapeutics Corp disclose cybersecurity risks?
Does Stealth BioTherapeutics Corp offer flexible work?
Does Stealth BioTherapeutics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Stealth BioTherapeutics Corp disclose the number of employees in R&D functions?
Does Stealth BioTherapeutics Corp conduct supply chain audits?
Does Stealth BioTherapeutics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Stealth BioTherapeutics Corp conduct 360 degree staff reviews?
Does Stealth BioTherapeutics Corp disclose the individual responsible for D&I?
Does Stealth BioTherapeutics Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Stealth BioTherapeutics Corp disclose current and / or historical scope 2 emissions?
Does Stealth BioTherapeutics Corp disclose water use targets?
Does Stealth BioTherapeutics Corp have careers partnerships with academic institutions?
Did Stealth BioTherapeutics Corp have a product recall in the last two years?
Does Stealth BioTherapeutics Corp disclose incidents of discrimination?
Does Stealth BioTherapeutics Corp allow for Work Councils/Collective Agreements to be formed?
Has Stealth BioTherapeutics Corp issued a profit warning in the past 24 months?
Does Stealth BioTherapeutics Corp disclose parental leave metrics?
Does Stealth BioTherapeutics Corp disclose climate scenario or pathway analysis?
Does Stealth BioTherapeutics Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Stealth BioTherapeutics Corp disclose the pay ratio of women to men?
Does Stealth BioTherapeutics Corp support suppliers with sustainability related research and development?
Does Stealth BioTherapeutics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Stealth BioTherapeutics Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Stealth BioTherapeutics Corp involved in embryonic stem cell research?
Does Stealth BioTherapeutics Corp disclose GHG and Air Emissions intensity?
Does Stealth BioTherapeutics Corp disclose its waste policy?
Does Stealth BioTherapeutics Corp report according to TCFD requirements?
Does Stealth BioTherapeutics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Stealth BioTherapeutics Corp disclose energy use targets?
Does Stealth BioTherapeutics Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Stealth BioTherapeutics Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Stealth BioTherapeutics Corp
These potential risks are based on the size, segment and geographies of the company.
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.